Ethris
Entity

  • Ethris

    Created in 2009
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    3,711

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Semmelweisstraße 3, 82152 Planegg, Germany

    Planegg

    Germany

  • Employees

    Scale: 51-200

    Estimated: 57

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    3 months, 3 weeks ago
Description
  • Value proposition

    Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform.

    Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners.

    Biotechnology, mRNA, LNPs, Vaccines, Therapeutics, Formulation, and Manufacturing

  • Home | ETHRIS

    Delivering the Future of RNA Medicine Today. . Ethris has created a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA (SNIM mRNA) and lipidoid nanoparticle (SNaP LNP) technology platforms to discover, design and develop innovative therapies and vaccines. As an mRNA pioneer for more than a decade, our technologies enable the delivery of highly potent m

    • https://www.ethris.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics